Ernestine Hull

Q: What is Ernestine Hull email address?

Email Ernestine Hull at ernestinehull@gmail.com and ernestine.hull@highmark.com. This email is the most updated Ernestine Hull's email found in 2026.

Q: How to contact Ernestine Hull?

To contact Ernestine Hull send an email to ernestinehull@gmail.com or ernestine.hull@highmark.com. (updated on August 25, 2024)

Senior Clinical Trial Associate at Marinus Pharma | Wayne, Pennsylvania, United States

About Ernestine Hull

Ernestine Hull is a dedicated Senior Clinical Trial Associate at Marinus Pharma, where she plays a pivotal role in the management of Phase II-III clinical trials focused on rare diseases. With a robust background in clinical research and health care management, Ernestine leads cross-functional teams to ensure the successful execution of clinical studies from feasibility assessments through to patient enrollment. Her expertise is particularly valuable in navigating the complexities of pediatric and adult clinical trials, where she applies her extensive knowledge of regulatory requirements and best practices to maintain Inspection Readiness of the Trial Master File (TMF).

At Marinus Pharma, Ernestine is currently spearheading several key projects aimed at advancing therapeutic developments for rare diseases. Her meticulous attention to detail and proactive approach to project management have been instrumental in streamlining processes and enhancing communication across teams. By leveraging her skills in public health and mental health, she fosters a collaborative environment that prioritizes patient safety and data integrity.

Ernestine’s commitment to health outcomes research further enriches her contributions, as she continually seeks to align clinical trial objectives with broader healthcare goals. Her leadership in the pharmaceutical industry is underscored by her ability to analyze complex data and translate findings into actionable insights, ensuring that each trial not only meets regulatory standards but also addresses the needs of diverse patient populations. As she continues to drive innovation and excellence in clinical research, Ernestine Hull remains a key asset to Marinus Pharma and the broader healthcare community.

Ernestine Hull Work